Analytical Method Development and Validation of Ivabradine Hydrochloride using Advanced Analytical Techniques

The current work intended to build a robust, precise, accurate, and specific HPLC method for the measurement of Ivabradine in tablet dosage form and in bulk, using an advanced analytical techniques.

Both perception and head part examination were used to control the basic bounds. In this investigation, an enhanced fluid chromatography method that may be used for the evaluation of Ivabradine HCL was developed through the use of the Quality by Design approach. The method was developed using the C18 segment and a portable stage that contained 0.1 M potassium dihydrogen orthophosphate and acetonitrile in the ratio 35:65 at a flow rate of 1.0 ml/min. A PDA indicator at 288 nm was used to finish the discovery process.

Under these perfect conditions, the baseline drug separation may be completed in less than 3.0 minutes with good resolution. The discovery procedure was completed by using a PDA indicator at 288 nm. The improved test settings were validated by adhering to ICH Q2 (R1) guidelines.

The methods that were suggested have been found to be effective and explicit, making them suitable for regular examination of the structure of tablets containing ivabradine hydrochloride.